Skip to main content
Premium Trial:

Request an Annual Quote

Akonni, Seegene Ink MDx Collaboration

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Akonni Biosystems and Seegene today said that they have signed an agreement to collaborate on the development of molecular diagnostic tests for infectious pathogens that cause respiratory diseases.

The collaboration will combine Seegene's Dual Priming Oligo multiplex PCR technology and Akonni's TruArray gel-drop microarray technology. The non-exclusive agreement is aimed at developing both point-of-care and ultra-high throughput diagnostic screening assays capable of simultaneously detecting a wide variety of pathogens from a single patient sample.

The partners said they believe the combined technologies will provide "more comprehensive and faster patient diagnosis, more timely delivery of appropriate treatments, a more streamlined workflow including end-to-end sample extraction through detection, and a significant reduction in overall assay and healthcare costs."

Frederick, Md.-based Akonni's TruArray tests run on its TruDx systems for point-of-care applications or its TruSentry system for multiplex genetic testing of up to 3,000 samples per day. Seoul, Korea-based Seegene's Dual Priming Oligo is a multiplexing PCR technology that enables simultaneous multi-pathogen detection.

Financial and other terms of the alliance were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.